股票行情快报：祥生医疗（688358）12月23日主力资金净卖出220.70万元

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Xiangsheng Medical (688358), indicating a decline in revenue and profit for the first three quarters of 2025 compared to the previous year [2] - As of December 23, 2025, Xiangsheng Medical's stock closed at 30.12 yuan, down 1.21%, with a turnover rate of 0.53% and a trading volume of 5,928 hands, amounting to a transaction value of 17.89 million yuan [1] - The company reported a main revenue of 343 million yuan for the first three quarters of 2025, a year-on-year decrease of 5.27%, and a net profit attributable to shareholders of 93.92 million yuan, down 4.56% year-on-year [2] Group 2 - In the third quarter of 2025, the company achieved a single-quarter main revenue of 107 million yuan, a decline of 6.68% year-on-year, while the single-quarter net profit attributable to shareholders increased by 41.95% to 24.22 million yuan [2] - The company has a debt ratio of 11.24% and reported investment income of 3.01 million yuan, with financial expenses of -16.53 million yuan and a gross profit margin of 59.82% [2] - Over the last 90 days, three institutions have given buy ratings for Xiangsheng Medical, indicating positive sentiment among analysts [3]